# Ocular, Periocular and Cutaneous Tolerance and Efficacy of Formula 2039002 10 in Patients With Palpebral Eczema

> **NCT05540496** · — · COMPLETED · sponsor: **Cosmetique Active International** · enrollment: 41 (actual)

## Conditions studied

- Eczema Eyelid

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05540496
- **Lead sponsor:** Cosmetique Active International
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-11
- **Primary completion:** 2021-04-17
- **Final completion:** 2021-04-17
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2022-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05540496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05540496, "Ocular, Periocular and Cutaneous Tolerance and Efficacy of Formula 2039002 10 in Patients With Palpebral Eczema". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05540496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*